Sleep Health Enhancement in Older Adults to Address Frailty

Purpose

The objective of the proposed study is to tailor a sleep health enhancement intervention to older adults and assess preliminary efficacy on reducing frailty in older adults. This pilot study will be conducted in two stages. In the treatment development stage, we will recruit n=10 older individuals age ≥65 with poor sleep health (≤ 7 on the Ru-SATED self-report questionnaire) to assess acceptability and tailor the sleep health enhancement intervention for older adults. In the pilot study stage to assess preliminary efficacy of the tailored sleep health enhancement intervention, n=30 older adults with poor sleep health will be randomly assigned to a 4-week 1x/week, telehealth-delivered sleep health enhancement intervention or to a wait-list control condition. Participants will wear wrist-worn actigraphy, complete sleep, frailty, and quality of life questionnaires at baseline and reassessments.

Condition

  • Frailty

Eligibility

Eligible Ages
Over 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • ≥65 years old - ≤ 7 on the RU-SATED self-report questionnaire - MMSE ≥25 and AD8 <3

Exclusion Criteria

  • Known untreated sleep disorder (such as sleep apnea or restless leg syndrome) - >3 on the STOP BANG indicating increased risk of sleep apnea - Evidence of restless legs syndrome on RLS-Diagnosis Index - Evidence of circadian rhythm sleep-wake disorder - Evidence of parasomnia - Regular use (>2x/week) of prescription or over-the-counter medications to improve sleep - Score of ≥15 on the Patient Health Questionnaire (PHQ-9) indicating severe depression or endorse any suicidal ideation (answer 1, 2 or 3 on #9 of the PHQ-9) - Score of ≥10 on the Generalized Anxiety Disorder (GAD-7) indicating moderate to severe anxiety - Self-report of current or history (up to 2 years) of drug or alcohol abuse based on the DSM-V criteria - History of nervous system disorder such as stroke or Parkinson's disease - Severe mental illness such as schizophrenia or bipolar disorder - Current or history (within 5 years) of shift work including hours of midnight-4am - Is currently receiving a behavioral sleep health intervention

Study Design

Phase
Phase 1
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Sleep Health Enhancement Intervention
The sleep health enhancement intervention is a 4-week, 1x/week one-one-one program with a graduate research assistant who will be trained and supervised by the PI in provision of the sleep health enhancement intervention.
  • Behavioral: Sleep Health Enhancement Intervention
    The program is based on principles from CBT-I (time in bed restriction, stimulus control, relaxation techniques, sleep education) and includes behavioral strategies to entrain circadian rhythm, strengthen sleep homeostasis, reduce hyperarousal, and sleep hygiene techniques. Self-Determination Theory (SDT) and Social Cognitive Theory (SCT) will serve as the theoretic framework for behavior change techniques (BCT) threaded through the sleep health enhancement intervention. Participants will maintain a sleep diary during the program to aid in tailoring the program, self-monitoring of behavior, and feedback of behavior. Goals will be set by the participant at each session and reviewed at subsequent sessions, and motivational interviewing principles will be incorporated.
No Intervention
Wait-List Control Group
The wait-list control group will be encouraged to continue with their usual activities and sleep habits during the wait period between baseline and reassessment and will undergo the sleep health enhancement intervention following the initial reassessment.

Recruiting Locations

University of Kansas Medical Center- Sleep, Health and Wellness Laboratory
Kansas City, Kansas 66160
Contact:
Eryen Nelson, MPH
913-945-7349
enelson5@kumc.edu

More Details

Status
Recruiting
Sponsor
University of Kansas Medical Center

Study Contact

Catherine Siengsukon, PhD
913-588-6913
csiengsukon@kumc.edu